Deal Description: Resilia Pharmaceuticals, Inc. announced the signing of a license agreement with Pelle Ventures, LLC granting Resilia the rights to make, market and sell Solace Eczema Cream as an OTC product in the United States. Financial terms of the transaction were not disclosed.
Baker Botts acted as legal advisor to Resilia Pharmaceuticals, Inc.
The company’s press release may be found here.
Baker Botts Lawyers/Offices Involved:
Corporate: Steve Mann (Partner, Dallas); Zachary Fedorko (Associate, Dallas)
Intellectual Property: Paul Ragusa (Partner, New York); Justine Gozzi (Special Counsel, New York)
Litigation: Edward Schorr (Special Counsel, New York)
ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm of approximately 650 lawyers practicing throughout a network of offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the energy, technology, and life sciences sectors. Since 1840, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.